Moleculin Biotech (MOL) Q3 2025 Earnings Report
DE:MOL Q3 2025 EPS Results
- Actual EPS
- -EUR 15.24
- Consensus EPS
- -EUR 5.89
- Beat/Miss
- Missed by -EUR 9.34
- One Year Ago EPS
- -EUR 63.80
DE:MOL Q3 2025 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 11/17/2025
- Time
- TBA
- Conference Call
- Monday, November 17, 2025
DE:MOL Upcoming Earnings
Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q3 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:MOL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | 2.34 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -27.82-25.07 | -219.37 | 88.57% (+194.30) | |
| May 15, 2026 | 2026 (Q1) | -41.79-63.39 | -308.91 | 79.48% (+245.52) | |
| Mar 19, 2026 | 2025 (Q4) | -109.4846.74 | 111.92 | -58.24% (-65.18) | |
| Nov 17, 2025 | 2025 (Q3) | -5.89-15.24 | -63.8 | 76.12% (+48.56) | |
| Aug 13, 2025 | 2025 (Q2) | -192.51-219.37 | -761.09 | 71.18% (+541.72) | |
| May 14, 2025 | 2025 (Q1) | -248.47-308.91 | -904.35 | 65.84% (+595.44) | |
| Mar 24, 2025 | 2024 (Q4) | -574.55111.92 | -2247.45 | 104.98% (+2359.37) | |
| Nov 11, 2024 | 2024 (Q3) | -1092.39-1275.94 | -1275.94 | 0.00% (+0.00) | |
| Aug 14, 2024 | 2024 (Q2) | -1123.72-761.09 | -1343.1 | 43.33% (+582.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
